RT Journal Article
SR Electronic
T1 Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP ijgc-2022-003419
DO 10.1136/ijgc-2022-003419
A1 Eduardo Paulino
YR 2022
UL http://ijgc.bmj.com/content/early/2022/02/20/ijgc-2022-003419.abstract
AB